The Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has expanded its multi-year subcontract with GenVec, Inc. This latest expansion of the subcontract increases the total potential funding from approximately $16 million to approximately $28 million. GenVec will manufacture a HIV vaccine Read more about Genvec And Nih Expand Hiv Vaccine Manufacturing Contract[…]